"Midkine Potential Announcements
considering Cellmid is a Biotech may also be a good idea ."
MJ the last investor presentation indicated that the company would complete pre-clinical development and file for orphan drug application in 2018 for,I think CAB102. There's not much of 2018 left but it would be a nice Christmas present if there was an announcement released.
CDY Price at posting:
30.5¢ Sentiment: Buy Disclosure: Held